CNBC Business

Delta Air Lines said it benefitted from strong travel demand and cheaper fuel.

PepsiCo raised its full-year outlook as it beat earnings and revenue estimates for the second quarter, but higher prices hurt its volume.

It's the latest bid for Fanatics to diversify as it heads toward a potential initial public offering.

The Autocado created by Chipotle and Vebu Labs could cut the prep time for the burrito chain's guacamole in half.

The Chinese government has "exploited" joint business ventures in search of companies' secrets and information, Wray told the House Judiciary Committee.

Iger had previously told CNBC that he had no intention to stay longer than two years in the post after he returned in November.

Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.

If talks break down between SAG-AFTRA and AMPTP, 160,000 actors will join striking writers on the picket lines.

United and other airlines are refreshing their cabins to include better technology and privacy to win over high-paying travelers.

Lucid built over 2,000 Air luxury sedans in the second quarter, but delivered just 1,404, adding to ongoing concerns about demand for the high-priced EV.

Luxury watch maker TAG Heuer, which is owned by LVMH, is riding a wave of marketing successes and new launches.

A recently unsealed lawsuit alleges sales reps from Medtronic, the world’s largest medical equipment company, operated a bribery scheme at a veteran hospital.

The European Commission last year blocked Illumina's $7.1 billion acquisition of Grail over concerns it would stifle innovation and consumer choice.

It's a destructive setback with potential ramifications for the company's customer United Launch Alliance and Blue Origin's own rocket New Glenn.

UAW president has vowed to be aggressive in bargaining with General Motors, Ford Motor and Stellantis for new worker contracts.

Brand management firm Go Global was eager to save Bed Bath & Beyond's crown jewel Buy Buy Baby, but it couldn't reach an agreement on valuation.

The European Medicines Agency didn't specify which additional GLP-1 drugs are now being investigated, but it could potentially include Eli Lilly's Mounjaro.

A representative from LIV Tour or the PIF will not be present at the hearing because the golf league's CEO, Greg Norman, is out of the country.

The analysis from Prime Therapeutics highlights the hefty price tag of Wegovy and other weight loss and diabetes medicines, which are also known as GLP-1s.

The announcement is the latest sign that some of the practices exposed by the Wells Fargo fake accounts scandal in 2016 weren't confined to that bank.